[1]
“Impact of Urinary NGAL in Predicting Response of β2 Microglobulin after Bortezomib Base Chemotherapy in Multiple Myeloma Patients”, Bangladesh Renal J., vol. 8, no. 1, pp. 16–23, Mar. 2026, doi: 10.3329/brej.v8i1.88160.